Clinical trial

A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study

NCT00567710

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-07-01

PhasePHASE2

Study timeline

Study start (unknown)2008-07-01Date precision: month

Registry last updated2010-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

BL - 1020DRUG

PlaceboDRUG

RisperidoneDRUG

Sponsors & collaborators

BioLineRx, Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00567710 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.